RecruitingSolid TumorsMetastatic Solid Tumors
A Study of DS3610a in Participants With Advanced Solid Tumor
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This study is designed to assess the safety, tolerability, and efficacy of DS3610a, given as a single agent to participants with advanced or metastatic solid tumors.
Sponsor: Daiichi Sankyo
Where it's recruiting
Wisconsin
Milwaukee
Source: ClinicalTrials.gov · NCT07159126 · last updated 2026-09-18